PL
GDRX icon

Parkwood LLC’s GoodRx Holdings GDRX Stock Holding History

Parkwood LLC’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,290
Closed -$682K – 163
2022
Q1 		$682K Buy
35,290
+17,883
+103% +$410K 0.11% 99
2021
Q4 		$569K Buy
+17,407
New +$700K 0.1% 88

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Parkwood LLC's GDRX Position: Q2 2022 in Review

Parkwood LLC sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 35,290 shares — an estimated $682K sold.

Parkwood LLC first reported a position in GDRX in Q4 2021 and held it in 2 quarters. The position peaked at $682K in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Parkwood LLC reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Parkwood LLC sold 35,290 GoodRx Holdings shares in Q2 2022, an estimated $682K.
  • Parkwood LLC first reported a position in GoodRx Holdings in Q4 2021 and held it in 2 quarters.
  • Parkwood LLC's GoodRx Holdings position peaked at $682K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Parkwood LLC's 13F filing for Q2 2022, filed 15 Aug 2022.